© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
January 17, 2021
Empiric broad-spectrum antimicrobial therapy, including coverage of MRSA and Pseudomonas aeruginosa, is generally recommended for healthcare-associated infections.
January 15, 2021
The bowel resting strategy might reduce switching from metronidazole to vancomycin among patients with Clostridioides difficile infection, but it might not reduce mortality or recurrence, a new study found.
January 08, 2021
December 26, 2020
Biologics have become a novel treatment in recurrent C. difficile.
December 14, 2020
An investigational microbiome-based therapeutic for C difficile was found to exert continued efficacy 3 months after administration.
December 06, 2020
Clostridium difficile infection (CDI) was associated with poorer outcomes, including a higher risk of mortality, among patients with chronic pancreatitis, an evaluation of the Nationwide Inpatient Sample database found.
December 04, 2020
Genetic sequencing can help assess how patient gut flora compares to donor both before and after FMT, study finds.
November 27, 2020
Interestingly, infection rates of the bacterium have decreased in 2020.
November 07, 2020
Investigators reported that 2 formulations of their C.diff vaccine produced injection site reaction that forced stoppage of the studies.
November 06, 2020
An investigational vaccine for C difficile demonstrates multiyear efficacy in trials reported at 2020 IDWeek Conference.